XML 35 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue (Tables)
9 Months Ended
Sep. 30, 2020
Revenue From Contract With Customer [Abstract]  
Schedule of Collaboration Revenue Revenue was as follows for the three and nine month periods ended September 30, 2020 and 2019:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Neurocrine Biosciences:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Recognition of the transaction price

 

$

5,246

 

 

$

 

 

$

23,006

 

 

$

 

    Research and development services

 

 

1,308

 

 

 

 

 

 

4,010

 

 

 

 

Flexion:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Recognition of the transaction price

 

 

 

 

 

3,000

 

 

 

 

 

 

3,000

 

    Milestone payment

 

 

 

 

 

500

 

 

 

 

 

 

500

 

Total collaboration revenue

 

$

6,554

 

 

$

3,500

 

 

$

27,016

 

 

$

3,500